Outcome Study Following Reimbursement Changes in the Use of Fixed Combination Inhalers in Patients With Asthma or Chronic Obstructive Pulmonary Disease

Completed

• Conditions: Asthma; Chronic Obstructive Pulmonary Disease

• Registration Number: NCT01369810
• Lead Sponsor: AstraZeneca

Brief Summary

To investigate how a switch from fixed combination treatment (ICS and LABA) to other treatments influence asthma or COPD treatment failure

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2011-06-08
• Study First Submitted QC: 2011-06-08
• Study First Posted: 2011-06-09
• Study Start: 2011-07
• Primary Completion: 2013-09
• Study Completion: 2013-09
• Status Verified: 2013-11
• Last Update Submitted: 2013-11-29
• Last Update Posted: 2013-12-02

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 20000

Inclusion Criteria

• All patients who was on treatment with fixed combination asthma or COPD therapy by January 1 2010

Exclusion Criteria

Not provided

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
To investigate how a switch from fixed combination treatment (ICS and LABA) to other treatments influence asthma or COPD treatment failure	Data will be extracted from the medical records and registries on one occassion, covering a period of 3 years

Secondary Outcome Measures

Name	Time	Method
To map out the development of asthma and COPD treatment in Iceland after the change in reimbursement	Data will be extracted from the medical records and registries on one occassion, covering a period of 3 years
To investigate health economic outcomes	Data will be extracted from the medical records and registries on one occassion, covering a period of 3 years

Trial Locations

Locations (1)

Research Site; 🇸🇪 Uppsala, Sweden